Trying to keep your blood sugar in range can be stressful. Our t:slim X2 insulin pump with Control‑IQ advanced hybrid closed-loop technology offers unique features to better manage your diabetes.
Control-IQ technology decreases or stops basal insulin if readings from compatible continuous glucose monitoring (CGM)* sensors are predicted to be low. It increases basal insulin if sensor readings are predicted to be high.
It can also deliver automatic correction boluses (up to one an hour) to help prevent hyperglycemia.†
Includes optional settings for Sleep Activity or Exercise Activity that adjust the range of treatment values.
For calibration or mealtime dosing, when the t:slim X2 insulin pump is integrated with compatible CGM.‡
The beauty of the t:slim X2 pump is that it is up to 38% smaller than other leading pumps,§ yet it can hold a large amount of insulin (up to 300 units).
Color Touchscreen
Easy to read for anyone familiar with a smart device
Custom Settings
Create up to six Personal Profiles
Rechargeable Battery
Convenient charging via micro-USB port
Watertight Construction
Tested to 0.91 meters for 30 minutes (IP27 rating)
Our remote software updates provide eligible t:slim X2 pump users access to future features and predictive technology without having to purchase new device hardware.^
An infusion set is a complete tubing system, changed every 2-3 days, which delivers insulin from the insulin pump to your body. Finding the right infusion set is an important part of successful insulin pump therapy, which is why we offer different options.
VariSoft: Variable angle soft cannula
TruSteel: 90-degree stainless steel needle
AutoSoft 90: 90-degree soft cannula
AutoSoft 30: 30-degree soft cannula
* CGM sold separately.
† If glucose values are predicted to be above 10,0 mmol/L, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 6,1 mmol/L and delivers 60% of that value.
‡ If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
§ 38% smaller than MiniMed 780G. Data on file, Tandem Diabetes Care.
^ Additional feature updates may not be currently available for the t:slim X2 insulin pump with Control-IQ technology. Control-IQ technology is available only to customers who reside in the United States or Canada, and other select geographies. Future updates for all or some of Tandem’s products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain future software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.
Important Safety Information
The t:slim X2 insulin pump with Control-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When used with a compatible CGM, the System can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The System can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The pump and the System are indicated for use in individuals 6 years of age and greater. The pump and the System are intended for single user use. The pump and the System are indicated for use with NovoRapid or Humalog U-100 insulin.
Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.
The System is not indicated for use in pregnant women, people on dialysis, or critically ill users. Do not use the System if using hydroxyurea. Users of the pump and the System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety info.
These infusion sets are indicated for the subcutaneous infusion of insulin administered by the t:slim X2 insulin pump for the treatment of diabetes. These infusion sets are indicated for single use. For contraindications, warnings, precautions, and other important information, please refer to the instructions for use accompanying the infusion sets.